INTRODUCTION: The Asian Pacific Association for the Study of the Liver (APASL) convened an international working party on the management of hepatocellular carcinoma (HCC) in December 2008 to develop consensus recommendations. METHODS: The working party consisted of expert hepatologist, hepatobiliary surgeon, radiologist, and oncologist from Asian-Pacific region, who were requested to make drafts prior to the consensus meeting held at Bali, Indonesia on 4 December 2008. The quality of existing evidence and strength of recommendations were ranked from 1 (highest) to 5 (lowest) and from A (strongest) to D (weakest), respectively, according to the Oxford system of evidence-based approach for developing the consensus statements. RESULTS: Participants of the consensus meeting assessed the quality of cited studies and assigned grades to the recommendation statements. Finalized recommendations were presented at the fourth APASL single topic conference on viral-related HCC at Bali, Indonesia and approved by the participants of the conference.
INTRODUCTION: The Asian Pacific Association for the Study of the Liver (APASL) convened an international working party on the management of hepatocellular carcinoma (HCC) in December 2008 to develop consensus recommendations. METHODS: The working party consisted of expert hepatologist, hepatobiliary surgeon, radiologist, and oncologist from Asian-Pacific region, who were requested to make drafts prior to the consensus meeting held at Bali, Indonesia on 4 December 2008. The quality of existing evidence and strength of recommendations were ranked from 1 (highest) to 5 (lowest) and from A (strongest) to D (weakest), respectively, according to the Oxford system of evidence-based approach for developing the consensus statements. RESULTS:Participants of the consensus meeting assessed the quality of cited studies and assigned grades to the recommendation statements. Finalized recommendations were presented at the fourth APASL single topic conference on viral-related HCC at Bali, Indonesia and approved by the participants of the conference.
Authors: K Kobayashi; T Sugimoto; H Makino; M Kumagai; M Unoura; N Tanaka; Y Kato; N Hattori Journal: Hepatology Date: 1985 Nov-Dec Impact factor: 17.425
Authors: Sung Hoon Yang; Kyung-Suk Suh; Hae Won Lee; Eung-Ho Cho; Jai Young Cho; Yong Beom Cho; Nam-Joon Yi; Kuhn Uk Lee Journal: Liver Transpl Date: 2006-11 Impact factor: 5.799
Authors: S Honjo; S Kono; M P Coleman; K Shinchi; Y Sakurai; I Todoroki; T Umeda; K Wakabayashi; K Imanishi; H Nishikawa; S Ogawa; M Katsurada; K Nakagawa; N Yoshizawa Journal: Ann Epidemiol Date: 1999-07 Impact factor: 3.797
Authors: H Oka; A Saito; K Ito; T Kumada; S Satomura; H Kasugai; Y Osaki; T Seki; M Kudo; M Tanaka Journal: J Gastroenterol Hepatol Date: 2001-12 Impact factor: 4.029
Authors: Hye Jin Yoo; Jeong Min Lee; Min Woo Lee; Soo Jin Kim; Jae Young Lee; Joon Koo Han; Byung Ihn Choi Journal: Invest Radiol Date: 2008-07 Impact factor: 6.016
Authors: Ragaa E Omer; Anneleen Kuijsten; Abdelgadir M Y Kadaru; Frans J Kok; Mohammed O Idris; Ibrahim M El Khidir; Pieter van 't Veer Journal: Nutr Cancer Date: 2004 Impact factor: 2.900
Authors: Robert J Wong; James Wantuck; Antonia Valenzuela; Aijaz Ahmed; Clark Bonham; Amy Gallo; Marc L Melcher; Glen Lutchman; Waldo Concepcion; Carlos Esquivel; Gabriel Garcia; Tami Daugherty; Mindie H Nguyen Journal: Dig Dis Sci Date: 2013-11-27 Impact factor: 3.199